Description

Glow Blend (70 mg) is a research peptide formulation composed of BPC-157, TB-500, and GHK-Cu, developed for experimental studies involving cellular repair processes, angiogenic signaling, and extracellular matrix regulation. This combination brings together peptides with complementary biological roles, allowing researchers to evaluate coordinated molecular responses in controlled laboratory settings.

BPC-157 is a short gastric-derived peptide fragment commonly investigated for its influence on nitric oxide pathways and growth factor signaling. TB-500, derived from Thymosin Beta-4, is frequently studied for its role in cytoskeletal organization, cell migration, and tissue remodeling through actin regulation. GHK-Cu, a copper-bound tripeptide complex, is widely researched for its interaction with metalloproteins, redox signaling balance, and matrix-related cellular activity.

At a total concentration of 70 mg, Glow Blend is well suited for research applications exploring regeneration-associated signaling, cytoprotective mechanisms, and peptide–metal interactions across a variety of experimental models.

This product is intended strictly for research use only and is not intended for human consumption, therapeutic use, or diagnostic application.

Representative scientific references include:

Sikiric P. et al., Current Pharmaceutical Design (2018)

Goldstein A.L. et al., Annals of the New York Academy of Sciences (2007)

Pickart L. et al., Biochimica et Biophysica Acta (2015)